Jasper Therapeutics, Inc. — Form 8-K
Filed October 5, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Jasper Therapeutics filed Form 8-K on October 5, 2026, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) for the period ending September 30, 2026. The filing does not disclose the specific nature, voting results, or details of the matters submitted. No dollar amounts, share counts, counterparties, or material business changes are specified in the document.
Why this rating
Routine 8-K filing disclosing shareholder vote; no material details provided; insufficient information to assess business impact.
Extracted items
See more from October 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.